Focus Stocks
Playing GameStop
Published on Wednesday, 08 February 2012 08:32 Written by TradersHuddle Wire
New York, February 8th (TradersHuddle.com) - Shares of GameStop Corporation (NYSE:GME) closed the trading session at $23.73 near its 50 day and 200 day moving averages currently set at $23.82 and $24.44 respectively. GameStop's price action is below these important levels, which makes the stock difficult to buy, as there will certainly be resistance as it approaches these important moving averages.
GameStop Corporation (NYSE:GME) operates specialty electronic game and PC entertainment software stores throughout the United States, Australia, Canada and Europe. The Company stores sell new and used video game hardware, video game software and accessories
Latest price action range, defined by a peaks and troughs algorithm placed calculated support at $23.17 and calculated resistance at $25.00. These levels should be watched by traders, as they provide insight into the latest price dynamics in GameStop shares.
Traders should evaluate their options if they want to establish a position on GameStop given the heavy resistance expected near the 50 and 200 day moving averages. A trade might be evident as the stock manages to break these moving averages, however until the break materializes buying the stock is nothing different than flipping a coin. Other levels that traders will closely evaluate are the ones defined by the peak and troughs algorithm that provides great price level reference points.
Related Articles
- GameStop Announces First-Ever Consumer EXPO at Annual Conference
- Is GameStop Closing in to Support?
- 52 Week Low: GameStop
- Critical Alerts For Priceline.com, Prudential, SanDisk, GameStop, and Under Armour Released By InvestorsObserver
- Stocks Fall for Fifth Day on Euro Woes and Weak Data
- GameStop Reports First Quarter 2012 Results
- Trading Idea: Is GameStop close to Support?
- GameStop Short term Bullish Reversal
- Stock Futures Lower as Banks take a Hit. Stocks to Watch: ANR, AAPL, BAC, GME, JPM, MCP, JWN, NUAN
- GameStop Pre-Announces First Quarter EPS and Same Store Sales Guidance
Related Partner Headlines
- GameStop Is In Decline, But The Rate Is Still Up For Debate - Investopedia
- GameStop Stock To Go Ex-dividend Tomorrow (GME) - TheStreet.com
- GameStop Corp Stock Downgraded (GME) - TheStreet.com
- UPDATE: Ascendiant Capital Markets Maintains Buy Rating, Lowers PT for GameStop - Benzinga
- GameStop: S&P Intraday Laggard - TheStreet.com
- GameStop Down 7% on Weak Q2 Guidance - Benzinga
- GameStop Corp (GME): Today's Featured Retail Winner - TheStreet.com
- Facebook Storefronts Do not Seem to be Working - Benzinga
- GameStop Stock To Go Ex-dividend Tomorrow (GME) - TheStreet.com
- Notable Put Options Activity in GameStop - Benzinga
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Toyota Is Back as May Sales Continue Auto Industry Recovery - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









